Search research articles
Contact Us
Filters
Showing results (1-10 of 340) with videos related to
Page
of 34
Sort By:
The Journal of Supportive Oncology
|
December 1, 2007
Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes
David I Rosenthal
Archives of Otolaryngology--Head & Neck Surgery
|
February 24, 2006
Established and emerging uses of cytoprotection in head and neck cancer
David I Rosenthal
Healthcare (Amsterdam, Netherlands)
|
August 8, 2015
Instant replay
David I Rosenthal
Seminars in Radiation Oncology
|
November 26, 2008
Strategies for managing radiation-induced mucositis in head and neck cancer
David I Rosenthal, Andrea Trotti
The New England Journal of Medicine
|
December 14, 2016
Meaning and the Nature of Physicians' Work
David I Rosenthal, Abraham Verghese
Seminars in Radiation Oncology
|
April 20, 2004
Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma
David I Rosenthal, K Kian Ang
Expert Review of Anticancer Therapy
|
July 9, 2005
Head and neck squamous cell carcinoma: optimizing the therapeutic index
David I Rosenthal, Angel I Blanco
Nature Clinical Practice. Oncology
|
November 3, 2005
Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
Sue S Yom, David I Rosenthal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2006
Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer
David I Rosenthal, Jan S Lewin, Avraham Eisbruch
Head & Neck
|
September 22, 2005
Postoperative treatment intensification for improving outcome in the high-risk patient: an evolutionary process
Randal S Weber, Merrill S Kies, David I Rosenthal
Page
of 34
Search research articles
Search
Showing results (1-10 of 340) with videos related to
Sort By:
Page
of 34
The Journal of Supportive Oncology
|
December 1, 2007
Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes
David I Rosenthal
Archives of Otolaryngology--Head & Neck Surgery
|
February 24, 2006
Established and emerging uses of cytoprotection in head and neck cancer
David I Rosenthal
Healthcare (Amsterdam, Netherlands)
|
August 8, 2015
Instant replay
David I Rosenthal
Seminars in Radiation Oncology
|
November 26, 2008
Strategies for managing radiation-induced mucositis in head and neck cancer
David I Rosenthal, Andrea Trotti
The New England Journal of Medicine
|
December 14, 2016
Meaning and the Nature of Physicians' Work
David I Rosenthal, Abraham Verghese
Seminars in Radiation Oncology
|
April 20, 2004
Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma
David I Rosenthal, K Kian Ang
Expert Review of Anticancer Therapy
|
July 9, 2005
Head and neck squamous cell carcinoma: optimizing the therapeutic index
David I Rosenthal, Angel I Blanco
Nature Clinical Practice. Oncology
|
November 3, 2005
Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
Sue S Yom, David I Rosenthal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2006
Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer
David I Rosenthal, Jan S Lewin, Avraham Eisbruch
Head & Neck
|
September 22, 2005
Postoperative treatment intensification for improving outcome in the high-risk patient: an evolutionary process
Randal S Weber, Merrill S Kies, David I Rosenthal
Page
of 34